Antigen Presentation And Cytokines
Help Questions
USMLE Step 1 › Antigen Presentation And Cytokines
A 27-year-old man has painful genital ulcers; PCR confirms HSV-2. Exam shows tender inguinal nodes; labs: elevated IFN-alpha. Viral antigen is processed endogenously and presented to cytotoxic T cells, limiting spread. Which MHC class molecule is involved in presenting the antigen in this scenario?
MHC class II
Secretory IgA
MHC class I
HLA-DQ
Explanation
This question tests understanding of antigen presentation and cytokine roles in immune responses. Antigen presentation involves MHC molecules, crucial for T cell activation, with cytokines modulating immune reactions. In this vignette, elevated IFN-alpha levels correlate with the patient's symptoms, as shown by genital ulcers in HSV-2 infection. Choice B is correct because MHC class I presents viral peptides to CD8+ T cells in intracellular infections. Choice A is incorrect as it misrepresents MHC class II's role, highlighting a common misconception about extracellular antigen processing. To aid learning, emphasize the distinction between MHC class I and II in viral immunity. Encourage practice with clinical scenarios to reinforce immune pathway understanding.
A 50-year-old man with chronic hepatitis B has fatigue and jaundice. Exam shows hepatomegaly; labs: ALT 220 U/L, HBV DNA high, elevated IFN-gamma. Viral peptides from infected hepatocytes are presented to cytotoxic T cells, causing hepatocyte injury. Which MHC class molecule is involved in presenting the antigen in this scenario?
HLA-DM
MHC class I
MHC class II
CD1
Explanation
This question tests understanding of antigen presentation and cytokine roles in immune responses. Antigen presentation involves MHC molecules, crucial for T cell activation, with cytokines modulating immune reactions. In this vignette, elevated IFN-gamma levels correlate with the patient's symptoms, as shown by elevated ALT in chronic HBV. Choice A is correct because MHC class I presents viral peptides to CD8+ T cells, causing hepatocyte injury. Choice B is incorrect as it misrepresents MHC class II's role, highlighting a common misconception about helper T cells in direct cytotoxicity. To aid learning, emphasize the distinction between MHC class I and II in chronic viral infections. Encourage practice with clinical scenarios to reinforce immune pathway understanding.
A 38-year-old woman has relapsing neurologic deficits and optic neuritis. MRI shows periventricular plaques; CSF shows oligoclonal bands; labs show elevated IL-2 and IFN-gamma. Antigen presentation of myelin proteins to CD4+ T cells drives inflammatory demyelination. Which MHC class molecule is involved in presenting the antigen in this scenario?
MHC class II
MHC class I
CD1
Complement C3
Explanation
This question tests understanding of antigen presentation and cytokine roles in immune responses. Antigen presentation involves MHC molecules, crucial for T cell activation, with cytokines modulating immune reactions. In this vignette, elevated IL-2 and IFN-gamma levels correlate with the patient's symptoms, as shown by plaques in multiple sclerosis. Choice B is correct because MHC class II presents myelin antigens to CD4+ T cells in autoimmune demyelination. Choice A is incorrect as it misrepresents MHC class I's primary role, highlighting a common misconception about cytotoxic responses in MS. To aid learning, emphasize the distinction between MHC classes in autoimmunity. Encourage practice with clinical scenarios to reinforce immune pathway understanding.
A 42-year-old man with chronic rheumatoid arthritis starts a TNF-alpha inhibitor. Two months later he develops cough, fever, and weight loss; CXR shows hilar adenopathy; interferon-gamma release assay is positive. Blocking TNF-alpha impaired granuloma maintenance despite ongoing antigen presentation. What is the most likely outcome if this cytokine pathway is inhibited?
Increased IgE production
Decreased risk of viral infections
Reactivation of latent tuberculosis
Enhanced neutrophil chemotaxis
Explanation
This question tests understanding of antigen presentation and cytokine roles in immune responses. Antigen presentation involves MHC molecules, crucial for T cell activation, with cytokines modulating immune reactions. In this vignette, TNF-alpha inhibition correlates with the patient's symptoms, as shown by cough and positive IGRA in TB reactivation. Choice A is correct because inhibiting TNF-alpha impairs granuloma maintenance, leading to latent TB reactivation. Choice B is incorrect as it misrepresents the outcome, highlighting a common misconception about Th2 shifts in TNF blockade. To aid learning, emphasize the distinction between MHC classes and cytokine roles in granulomatous diseases. Encourage practice with clinical scenarios to reinforce immune pathway understanding.
A 52-year-old woman undergoes liver transplantation and develops fever and jaundice 7 days later. Exam shows RUQ tenderness; labs: AST 410 U/L, ALT 380 U/L; biopsy shows portal inflammation with lymphocytes and endothelialitis. Donor antigens are presented to recipient T cells, amplifying inflammation via cytokines. Which MHC class molecule is involved in presenting the antigen in this scenario?
CD1
Fc receptor
MHC class I
MHC class II
Explanation
This question tests understanding of antigen presentation and cytokine roles in immune responses. Antigen presentation involves MHC molecules, crucial for T cell activation, with cytokines modulating immune reactions. In this vignette, antigen presentation correlates with the patient's symptoms, as shown by elevated liver enzymes in transplant rejection. Choice B is correct because MHC class II presents donor antigens to CD4+ T cells in acute cellular rejection. Choice A is incorrect as it misrepresents MHC class I's primary role, highlighting a common misconception about helper versus cytotoxic responses. To aid learning, emphasize the distinction between MHC class I and II in transplant immunology. Encourage practice with clinical scenarios to reinforce immune pathway understanding.